Targeted lung cancer screening in the age of immunotherapies and targeted therapies – an economic evaluation for Australia

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Western Pacific
Published
2024-11-25
DOI
https://doi.org/10.1016/j.lanwpc.2024.101241
Citations
5
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted lung cancer screening in the age of immunotherapies and targeted therapies – an economic evaluation for Australia

Kevin ten Haaf, Jonathan D. Karnon, D. Keefe, Vivienne Milch et al.
5 citations
The Lancet Regional Health - Western Pacific
Lung Cancer Diagnosis and Treatment
2.09
article

Targeted lung cancer screening in the age of immunotherapies and targeted therapies – an economic evaluation for Australia

Kevin ten Haaf, Jonathan D. Karnon, D. Keefe, Vivienne Milch, Jacqueline Roseleur, Katrina Anderson, Harry J. de Koning, Jacqui Real
article en
5 citations

Abstract

No abstract available for this paper.
The Lancet Regional Health - Western PacificVol. 53
Flinders University (AU), Erasmus MC (NL), Cancer Australia (AU)
Bayer, Teva Pharmaceutical Industries, European Commission, Cancer Australia, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health
Openalex Percentile: Top 12%
Lung Cancer Diagnosis and Treatment
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.